PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients

NCT06359275 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: PD-1
DRUG: Nab-paclitaxel
DRUG: Gemcitabine
RADIATION: PULSAR

Sponsor

Fudan University